# Oteseconazole in the Treatment of Adults With Vulvovaginal Candidiasis（VVC）

> **NCT07044947** · — · NOT_YET_RECRUITING · sponsor: **Beijing Tsinghua Chang Gung Hospital** · enrollment: 3000 (estimated)

## Conditions studied

- Vulvovaginal Candidiasis

## Interventions

- **DRUG:** Oteseconazole (VT-1161) 150mg capsule

## Key facts

- **NCT ID:** NCT07044947
- **Lead sponsor:** Beijing Tsinghua Chang Gung Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-10
- **Primary completion:** 2027-08-10
- **Final completion:** 2030-08-10
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07044947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07044947, "Oteseconazole in the Treatment of Adults With Vulvovaginal Candidiasis（VVC）". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07044947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*